Interestingly, increased GSK3β activity has also been implicated in Alzheimer’s disease (AD) pathology, including the disruption of synaptic plasticity62, 63 and memory processing64. This evidence concerns the gene GSK3B and early-onset autosomal dominant Alzheimer disease.